Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

RedHill Says Its Oral Antivirals, Opaganib And RHB-107, Inhibit Dominant Omicron Sub-Variant BA.5

Por: RTTNews Health October 03, 2022

thumbnail

Specialty biopharmaceutical company RedHill Biopharma Ltd. () announced Monday the study results showing in vitro efficacy against the currently dominant Omicron COVID-19 sub-variant BA.5, by both of RedHill's novel, oral, host-directed and broad-acting investigational antivirals, once-daily RHB-107 (upamostat) and twice-daily opaganib.These results build on previously reported data on the inhibition of COVID-19, variants of concern and... + full article



Similar News

Supreme Court confirms public can attend hearings in October for first time since Covid lockdown of March 2020

CNBC USA Politics September 29, 2022

thumbnailA crosswalk signal is seen outside the U.S. Supreme Court building in Washington, U.S., June 27, 2022.Elizabeth Frantz ReutersThe Supreme Court starting Monday will allow members of the public to attend oral argument hearings for the first time since the Covid-19 lockdown of... + más

David Shapiro: US Supreme Court vs. states’ highest courts: We are giving kids the wrong message. | Chicago Tribune

Justice Ketanji Brown Jackson makes Supreme Court debut | New York Daily News


Sonos Sub Mini review: a cheaper subwoofer for its other wireless speakers

Newsweek USA Tech September 29, 2022

thumbnailIn gadget lore, a smaller, less expensive subwoofer from Sonos ranks pretty high. As much as the Sonos Sub has been coveted for around a decade, its current $749 price has kept it out of reach for a lot of people who might want one. The demand among Sonos customers for a cheaper... + más

iOS 16.1 hints at new way to group multiple HomePods and AirPlay 2 speakers | 9to5Mac

Easier than a plug: Wireless EV charging gets ready for prime time | Ars Technica


Sonos Sub Mini review: low end for a lower price

The Verge USA Tech September 29, 2022

thumbnailSonos Sub Mini review: low end for a lower priceThe long-awaited $429 Sub Mini doesn’t disappoint, but there are still reasons to opt for the standard SubBy / time]:lg:block mb-4 [&>time]:leading-120> Sep 29, 2022, 1:00 PM UTC Share this storya]:text-black>If you buy something... + más

Sonos Sub Mini review: a cheaper subwoofer for its other wireless speakers | Newsweek

White House renews call to ‘remove’ Section 230 liability shield | Politico


Omicron-specific vaccine boosters get FDA sign-off

The Verge USA Health September 24, 2022

thumbnailOmicron-specific vaccine boosters get FDA sign-offOmicron-specific vaccine boosters get FDA sign-off / It’s the first update to COVID-19 vaccinesp>span:first-child]:text-black text-blurple>By Aug 31, 2022, 1:54 PM UTC Share this story a:hover]:text-black... + más

Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old | CNBC

Here’s Why Experts Believe the New Omicron Booster Will Work | Time


Here’s How Effective the Original Vaccines Are Against Omicron

Time USA Health September 24, 2022

thumbnailIn a today, scientists report on how effective the original vaccine and booster shots are against the COVID-19 Delta and Omicron variants. Researchers in Ontario analyzed data from more than 134,000 people, including those who tested positive for Delta and Omicron infections... + más

Omicron-specific vaccine boosters get FDA sign-off | The Verge

Here’s Why Experts Believe the New Omicron Booster Will Work | Time


Here’s Why Experts Believe the New Omicron Booster Will Work

Time USA Health September 24, 2022

thumbnailA published Sept. 16 in the New England Journal of Medicine (NEJM) makes a strong case for an Omicron-based COVID-19 booster shot. But first, a caveat: There are no data available yet demonstrating the effectiveness of the new Omicron booster on Aug. 31, which protects against... + más

Moderna-backed mouse study offers first head-to-head BA.5, BA.1 booster data | Ars Technica

Here’s How Effective the Original Vaccines Are Against Omicron | Time


Mystery as to why new COVID variants have stalled in growth

ABC News USA Health September 19, 2022

thumbnailThroughout much of the pandemic, there has been a constant shifting in terms of which COVID-19 variants are most dominant, at a given time, in the U.S.However, for the last five weeks, federal data shows that there has been little to no growth in the different proportions of... + más

US clears updated COVID boosters targeting newest variants | 10 WBNS

US clears updated COVID boosters targeting newest variants | ABC News



About iurex | Privacy Policy | Disclaimer |